Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities
Net income	$ 1,344.9	$ 1,902.9
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:
Depreciation and amortization	362.3	435.7
Change in deferred income taxes	(559.4)	(506.6)
Stock-based compensation expense	131.2	101.0
Net investment losses	14.2	426.1
Acquired in-process research and development (Note 3)	105.0	165.6
Other changes in operating assets and liabilities, net of acquisitions and divestitures	164.1	(34.3)
Other operating activities, net	168.3	32.6
Net Cash Provided by Operating Activities	1,730.6	2,523.0
Cash Flows from Investing Activities
Purchases of property and equipment	(668.5)	(365.4)
Proceeds from sales and maturities of short-term investments	61.5	26.7
Purchases of short-term investments	(23.0)	(14.6)
Proceeds from sales of and distributions from noncurrent investments	281.9	81.4
Purchases of noncurrent investments	(146.0)	(116.7)
Purchases of in-process research and development	(235.0)	(515.6)
Other investing activities, net	40.3	(133.4)
Net Cash Used for Investing Activities	(688.8)	(1,037.6)
Cash Flows from Financing Activities
Dividends paid	(1,017.2)	(885.5)
Net change in short-term borrowings	(1,498.0)	499.7
Proceeds from issuance of long-term debt	3,958.5	0.0
Repayments of long-term debt	0.0	(710.1)
Purchases of common stock	(750.0)	(1,500.0)
Other financing activities, net	(281.0)	(282.4)
Net Cash Provided by (Used for) Financing Activities	412.3	(2,878.3)
Effect of exchange rate changes on cash and cash equivalents	24.8	33.6
Net increase (decrease) in cash and cash equivalents	1,478.9	(1,359.3)
Cash and cash equivalents at January 1	2,067.0	3,818.5
Cash and Cash Equivalents at March 31	$ 3,545.9	$ 2,459.2